Kevin Hern's CL trades
- The latest CL trade was a sale on Sep 2, 2026, when CL closed at $90.10. It closed at $99.14 on Nov 20, 2026 (+10%).
Price changes use the closing price on each trade date, not the price actually paid, and ignore dividends. Filings report amounts only as ranges, so these figures show direction, not anyone's actual profit.
Kevin Hern reported 4 CL transactions in 2 filings with the House Clerk for 2025–2026: 0 purchases and 4 sales of Colgate-Palmolive Company, with trade dates from Aug 19, 2026 to Sep 2, 2026. The median gap between trade date and filing date is 24 days, and every trade was reported within 45 days.
- 4
- 0 / 4
- $4K to $60K
- 2026-09-25
CL transactions reported by Kevin Hern
| Type | Owner | ||||
|---|---|---|---|---|---|
Colgate-Palmolive Company Common Stock CL | Sale | Joint | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Colgate-Palmolive Company Common Stock CL | Sale | Self | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Colgate-Palmolive Company Common Stock CL | Sale | Self | $1,001 - $15,000 | 2026-09-25 #20035491 | |
Colgate-Palmolive Company Common Stock CL | Sale | Joint | $1,001 - $15,000 | 2026-09-01 #20035326 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
How long disclosure took
Days from trade date to filing date for 4 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 1
- 16–30 days
- 3
- 31–45 days
- 0
- Over 45 days
- 0
- Median / longest
- 24d / 29d
What Kevin Hern's CL filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Colgate-Palmolive Company financials and filings
Audited SEC figures, what moves CL, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- Issue 09: Is Nvidia Stock a Buy at 10x Earnings Without Huang?
At $155.46, Nvidia trades at 9.8 times next year's expected earnings, about half the S&P 500's multiple. What the price assumes, and our three calls.
- Issue 08: Who Pays for a 5% Treasury? Stocks Hurt by Rising Rates
Homebuilders fall about five times as much as the S&P 500 when Treasury yields rise, and banks don't gain. Our 2026 rate screen, valuations and three calls.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchOther members of Congress who reported CL
More tickers reported by Kevin Hern
Kevin Hern and CL: questions
Did Kevin Hern buy or sell CL?
House Clerk filings for 2025 and 2026 show 0 purchases and 4 sales of Colgate-Palmolive Company (CL) reported by Kevin Hern, between 2026-08-19 and 2026-09-02. Reported owners: Joint, Self.
How much CL did Kevin Hern trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K to $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last CL filing by Kevin Hern?
The most recent filing that includes a CL trade was filed on 2026-09-25. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Colgate-Palmolive Company. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Kevin Hern CL disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included